(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -193.56%-1.79B | -32.34%1.02B | -39.84%767M | 19.48%6.68B | 3.33%1.99B | 24.76%1.91B | 33.90%1.51B | 26.11%1.28B | -24.99%5.59B | -4.14%1.92B |
Net income from continuing operations | 166.44%1.38B | 116.84%1.15B | -4.89%933M | -220.51%-6.98B | 74.40%947M | -153.61%-2.07B | -8,436.59%-6.84B | -24.71%981M | -2.33%5.79B | -59.48%543M |
Operating gains losses | 2,650.00%55M | 2,121.05%844M | 45.95%54M | 104.28%109M | -40.74%32M | 100.07%2M | -5.00%38M | -13.95%37M | -1,335.92%-2.55B | -21.74%54M |
Depreciation and amortization | -42.06%310M | -32.96%301M | -7.73%430M | 8.52%1.99B | 16.74%537M | 18.89%535M | -2.81%449M | 1.53%466M | -4.39%1.83B | -9.27%460M |
Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --889M | ---- |
Remuneration paid in stock | -8.70%42M | 317.07%171M | -78.52%29M | 4.18%274M | 40.54%52M | 4.55%46M | -12.77%41M | 0.00%135M | -4.01%263M | -21.28%37M |
Deferred tax | 119.33%178M | 98.82%-29M | 254.84%144M | -481.45%-3.86B | -130.36%-387M | -1,993.18%-921M | -510.45%-2.45B | -89.80%-93M | -299.40%-663M | -1,427.27%-168M |
Other non cashItems | -192.78%-3.84B | -108.66%-940M | -200.37%-805M | 2,030.32%14.83B | 118.75%102M | 1,193.44%4.14B | 526.67%10.85B | 67.00%-268M | 1,380.85%696M | -1,136.36%-544M |
Change In working capital | -48.89%92M | 18.18%-477M | -205.88%-18M | 147.31%317M | 7.99%703M | 142.96%180M | 30.10%-583M | 125.00%17M | 10.79%-670M | 571.13%651M |
-Change in receivables | 500.00%132M | 55.31%-143M | -4.11%-76M | -61.90%-170M | -44.48%201M | 320.00%22M | -19.40%-320M | 61.38%-73M | 13.93%-105M | 79.21%362M |
-Change in inventory | -27.41%98M | -1,390.00%-129M | -254.95%-141M | 190.14%567M | -14.91%331M | 174.59%135M | 101.93%10M | 128.53%91M | 30.34%-629M | 586.25%389M |
-Change in payables and accrued expense | -700.00%-138M | 24.91%-205M | 20,000.00%199M | -225.00%-80M | 271.00%171M | 110.09%23M | -468.75%-273M | -100.23%-1M | -76.64%64M | -300.00%-100M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -193.56%-1.79B | -32.34%1.02B | -39.84%767M | 19.48%6.68B | 3.33%1.99B | 24.76%1.91B | 33.90%1.51B | 26.11%1.28B | -24.99%5.59B | -4.14%1.92B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -319.51%-1.2B | -98.71%-463M | -1.81%-393M | -15.39%-1.21B | 22.42%-301M | -283.97%-287M | 57.71%-233M | -46.77%-386M | 20.58%-1.05B | -437.39%-388M |
Net PPE purchase and sale | 22.29%-244M | 33.61%-237M | 25.00%-354M | 3.42%-1.5B | 4.85%-353M | 26.29%-314M | 7.03%-357M | -28.26%-472M | 0.19%-1.55B | 32.42%-371M |
Net business purchase and sale | ---- | ---- | ---- | -87.78%60M | --0 | ---- | ---- | ---- | --491M | --0 |
Net investment purchase and sale | -4,480.95%-962M | -367.86%-225M | -112.79%-11M | 1,663.64%194M | 364.71%45M | -123.33%-21M | 154.55%84M | -6.52%86M | -94.61%11M | -102.61%-17M |
Net other investing changes | 116.67%2M | ---1M | ---28M | 3,400.00%35M | --7M | -185.71%-12M | ---- | ---- | -96.77%1M | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -319.51%-1.2B | -98.71%-463M | -1.81%-393M | -15.39%-1.21B | 22.42%-301M | -283.97%-287M | 57.71%-233M | -46.77%-386M | 20.58%-1.05B | -437.39%-388M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -54.12%-1.09B | -69.12%-1.36B | 745.39%4.62B | 41.18%-3.15B | 29.73%-924M | 24.54%-704M | 23.38%-803M | 65.14%-716M | 12.94%-5.35B | 45.48%-1.32B |
Net issuance payments of debt | --0 | --0 | 12,911.63%5.51B | 94.51%-46M | ---108M | 2,750.00%106M | 99.60%-1M | 92.64%-43M | 26.81%-838M | --0 |
Net common stock issuance | -33,650.00%-675M | ---400M | 27.59%-21M | 97.75%-33M | 99.63%-2M | 98.71%-2M | --0 | 96.25%-29M | 33.42%-1.46B | 42.86%-536M |
Cash dividends paid | 53.74%-383M | 53.38%-386M | -0.97%-835M | 1.72%-3.31B | -1.10%-828M | 2.59%-828M | 2.36%-828M | 2.93%-827M | 1.49%-3.37B | 3.42%-819M |
Proceeds from stock option exercised by employees | 40.74%38M | -61.29%12M | -90.37%18M | -30.71%264M | -73.24%19M | -67.47%27M | -50.79%31M | 14.02%187M | -40.38%381M | -2.74%71M |
Net other financing activities | -828.57%-65M | -11,580.00%-584M | -1,150.00%-50M | 65.00%-21M | 83.87%-5M | 0.00%-7M | 61.54%-5M | 55.56%-4M | -200.00%-60M | -3,200.00%-31M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -54.12%-1.09B | -69.12%-1.36B | 745.39%4.62B | 41.18%-3.15B | 29.73%-924M | 24.54%-704M | 23.38%-803M | 65.14%-716M | 12.94%-5.35B | 45.48%-1.32B |
Net cash flow | ||||||||||
Beginning cash position | 136.80%10.08B | 185.33%10.91B | 62.33%5.93B | -19.92%3.66B | 51.00%5.14B | 56.43%4.26B | 17.77%3.82B | -19.92%3.66B | -1.51%4.56B | -30.22%3.4B |
Current changes in cash | -543.53%-4.08B | -269.13%-800M | 2,787.28%5B | 388.94%2.33B | 247.49%761M | 21.88%919M | 200.21%473M | 113.25%173M | -9,962.50%-805M | 175.00%219M |
Effect of exchange rate changes | 216.22%43M | 28.21%-28M | -325.00%-17M | 53.85%-48M | 0.00%32M | 48.61%-37M | 26.42%-39M | 63.64%-4M | -67.74%-104M | 245.45%32M |
End cash Position | 17.70%6.05B | 136.80%10.08B | 185.33%10.91B | 62.33%5.93B | 62.33%5.93B | 51.00%5.14B | 56.43%4.26B | 17.77%3.82B | -19.92%3.66B | -19.92%3.66B |
Free cash from | -235.08%-2.03B | -33.57%752M | -51.00%392M | 31.83%5.07B | 14.97%1.63B | 37.32%1.51B | 52.36%1.13B | 36.29%800M | -34.34%3.84B | -2.28%1.42B |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data